biote Corp.
Market Cap
$65.08M
P/E Ratio
1.84
EPS
$0.74
Dividend Yield
0.00%
52-Week Range
$1.35 — $4.75
Volume
353.22K
Avg Volume
184.15K
Beta
1.14
P/E (TTM)
1.84
Forward P/E
3.44
PEG Ratio
-0.24
P/S (TTM)
0.35
P/B (TTM)
-0.73
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.35%
ROA (TTM)
0.25%
ROIC
—
Gross Margin
0.71%
Operating Margin
0.18%
Net Margin
—
Debt/Equity
-0.16
Current Ratio
1.22
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.23%
EPS Growth (5Y)
-0.03%
Sales Growth (3Y)
+0.12%
Sales Growth (5Y)
+0.13%
EPS Est (This Year)
$0.40
EPS Est (Next Year)
$0.65
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.79
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
47.85M
Float
43.55M
Free Float %
91.02%
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NASDAQ
IPO Date
2021-04-28
Employees
217
CEO
Bret Christensen
Index Membership
—
Website
https://biote.com
biote Corp. (BTMD) is a healthcare company in the medical - care facilities industry listed on the NASDAQ. With a market capitalization of $65.08M, a P/E ratio of 1.84, BTMD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BTMD against other stocks using dozens of fundamental and technical filters.
biote Corp. (BTMD) has a trailing twelve-month (TTM) P/E ratio of 1.84. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, biote Corp. (BTMD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
biote Corp. (BTMD) has a market capitalization of $65.08 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.